Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

NCT00393796 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Bladder Cancer

Interventions

DRUG: SUTENT
OTHER: Placebo

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]